Asporelix® (Cetrorelix Acetate) Cetrorelix acetate 0.25 mg injection by Bharat Serums and Vaccines. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Cetrorelix acetate 0.25 mg |
|---|---|
| Manufacturer | Bharat Serums and Vaccines |
| Country | India |
| Pack size | Cetrorelix acetate 0.25 mg: 1 vial with diluent / carton |
| Storage | Store as per carton and leaflet; original sealed pack |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Asporelix® (Cetrorelix Acetate) Cetrorelix acetate 0.25 mg Injection — GnRH Antagonist for Injection: A Sourcing Guide for Hospitals and Pharmacies
Asporelix® is a brand of cetrorelix acetate for injection, a gonadotropin-releasing hormone (GnRH) antagonist, marketed by Bharat Serums and Vaccines. According to the reference US prescribing information for cetrorelix (Cetrotide®), the product class is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian stimulation. Use of Asporelix in India is defined by its approved pack insert and the Indian regulator. The decision to prescribe cetrorelix acetate, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Asporelix® (cetrorelix acetate) Cetrorelix acetate 0.25 mg injection to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the hormone medicines category. Supply is in bulk/wholesale quantities only.
Asporelix contains cetrorelix acetate 0.25 mg, a synthetic peptide that blocks GnRH receptors. It is supplied as a sterile injection and is used only under the supervision of a physician experienced in fertility treatment, as the reference label states.
How it works, according to the label: The reference label describes cetrorelix as a GnRH antagonist that competitively blocks GnRH receptors on pituitary cells, which suppresses the release of LH and follicle-stimulating hormone (FSH).
The current US prescribing information for Cetrotide® (cetrorelix acetate for injection), the reference brand of the same molecule (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Asporelix pack insert.
The reference label summarises its clinical studies in women undergoing controlled ovarian stimulation. An early dose-finding study of single-dose cetrorelix in IVF and embryo transfer was published by Olivennes et al. in Human Reproduction in 1998. Evidence is cited for information only and is not a recommendation for any patient; the approved prescribing information governs.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Cetrorelix acetate 0.25 mg | Powder for solution for injection, subcutaneous | 1 vial with diluent / carton |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
This page is written for fertility clinics, hospital pharmacists and pharmacies that source assisted-reproduction injectables. Cetrorelix is prescribed and supervised by a physician, as described in the prescribing information.
The reference label lists injection-site reactions, mild and transient, and ovarian hyperstimulation syndrome (OHSS) among the reported adverse reactions in women undergoing ovarian stimulation, together with nausea and headache. It also describes rare allergic and anaphylactic reactions. This list is not complete; the full prescribing information governs.
All use should follow the approved prescribing information and the instructions of the treating physician.
Please follow the storage instructions printed on the Asporelix carton and leaflet. For reference, the US Cetrotide label describes refrigeration at 2°C to 8°C with the tray kept in the outer carton to protect from light. Keep out of reach of children.
Asporelix is marketed by Bharat Serums and Vaccines. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Asporelix through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Asporelix available in India?
A.K. Pharma supplies Asporelix (cetrorelix acetate) Cetrorelix acetate 0.25 mg injection to hospitals and pharmacies in India. Contact us for current availability.
What does Asporelix contain?
Cetrorelix acetate 0.25 mg, a GnRH antagonist supplied as an injection for use in ovarian stimulation under a fertility specialist.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Asporelix be stored?
Follow the carton; the US reference label describes 2°C to 8°C, protected from light in the outer carton.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
